BCPC vs IFF
BCPC: Balchem is a leading developer of specialty performance ingredients and solutions for the food, animal health, and pharmaceutical industries, with a strong focus on high-value microencapsulation and specialty chemical technologies. IFF: A global leader in the science and artistry of taste, scent, and bioscience, supplying essential ingredients for the world's most recognized consumer and industrial brands.
Side-by-side fundamentals
| Metric | BCPC | IFF | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $167.56 | $79.22 | |
| Market cap as of 2026-08-03 | $5.3B | $20.2B | |
| P/E as of 2026-08-03 | 34.41 | 23.89 | IFF lower |
| PEG as of 2026-08-03 | 1.94 | 3.16 | BCPC lower |
| Net margin as of 2026-08-03 | +14.9% | +7.9% | BCPC higher |
| Gross margin as of 2026-08-03 | +36.3% | +36.4% | IFF higher |
| Operating margin as of 2026-08-03 | +20.2% | +11.1% | BCPC higher |
| ROE as of 2026-08-03 | +12.4% | +6.0% | BCPC higher |
| ROA as of 2026-08-03 | +9.4% | +3.3% | BCPC higher |
| Debt / equity as of 2026-08-03 | 0.13 | 0.41 | BCPC lower |
| Revenue growth (YoY) as of 2026-08-03 | +9.6% | -5.6% | BCPC higher |
| Revenue CAGR (3y) SEC XBRL | +3.2% | -4.3% | BCPC higher |
| Dividend yield as of 2026-08-03 | +0.6% | +2.0% | IFF higher |
| Dividend streak (yrs) SEC XBRL | 4 | 2 | BCPC higher |
| Beta as of 2026-08-03 | 0.54 | 0.65 | |
| 1-year return as of 2026-07-31 close | +9.9% | +11.5% | IFF higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.